Send to a Friend Share

Momenta Pharma (MNTA) Posts Q3 Loss of $0.38, Tops by 2c

November 5, 2009 9:31 AM EST
MNTA Hot Sheet
Revenue Growth %: -69.1%

Financial Fact:
Interest income: 307K

Today's EPS Names:
TARO, BRLI, TLB, More
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) reports Q3 loss of $0.38, 2 cents better than the analyst estimate of ($0.40). Revenue for the quarter was $4 million, which compares to the estimate of $4.74 million.

You May Also Be Interested In


Related Categories

Earnings

Add Your Comment





Follow StreetInsider.com On Twitter